NIAID

NIH study of anti-CD14 antibody to treat COVID-19 respiratory disease begins

NIH experts discuss post-acute COVID-19

NIH Experts Call for Accelerated Research to Address Simultaneous HIV and COVID-19 Pandemics

NIH and BARDA Statement on FDA Emergency Use Authorization for Janssen COVID-19 Vaccine, February 27, 2021

NIH experts discuss the viral variants of SARS-CoV-2

Four Potential COVID-19 Therapies Enter Phase 2/3 Trial in NIH ACTIV-2 Trial

Intranasal flu vaccine stimulates strong immune response in phase 1 study

Janssen Investigational COVID-19 Vaccine: Interim analysis of Phase 3 clinical data released

Peer-reviewed report on Moderna COVID-19 vaccine publishes

Phase 3 study of the Novavax COVID-19 vaccine opens